Skip to content

Elevance Health, Inc.

Elevance Health

ELV · NYSE

Healthcare

Catalog as of September 15, 2026. Not a live market feed.

Fiscal Year
2025
Revenue
$199.1B
Assets
$121.5B
SEC filing
DEF 14A
Filed
March 27, 2026

Executive Compensation

Compensation reported for Elevance Health’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.

Gail Boudreaux

President And Chief Executive Officer (ceo)

$22.6M

Reported total · FY2025 · SCT Total as filed

Source: DEF 14A Summary Compensation Table, filed March 27, 2026.

Salary
$1.6M
Stock Awards
$13.4M
Option Awards
$4.2M
Incentives
$2.8M
Other
$574K

Historical Compensation

Gail Boudreaux total compensation, fiscal years 2023–2025.

Year-by-year total compensation
Fiscal YearSalaryTotal Compensation
2025$1,600,000$22,582,314
2024$1,600,000$20,471,976
2023$1,600,000$21,889,039

Named Executive Officers

Source information

Company
Elevance Health, Inc.
Ticker
ELV · NYSE
Filing type
DEF 14A
Fiscal year
2025
Filing date
March 27, 2026
SEC accession number
0001156039-26-000031

Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing

Related Companies